X. Ni

发表

Utility of a single serum testosterone measurement to determine response to topical testosterone replacement in hypogonadal men

D. Muram, X. Ni, 2016, Current medical research and opinion.

Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other Than Premature Ejaculation: A Prospective, Observational Study.

D. Paduch, A. Morgentaler, S. Althof, 2015, The journal of sexual medicine.

Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment

C. Roehrborn, R. Rosen, M. Miner, 2016, BJU international.

Do baseline estrogen and testosterone affect lower urinary tract symptoms (LUTS) prior to or after pharmacologic treatment with tadalafil?

C. Roehrborn, G. Wittert, K. McVary, 2015, Andrology.

Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases

M. Oelke, J. Mulhall, M. Rosenberg, 2016, The journal of sexual medicine.

Ef fi cacy of Continuous Dosing of Tadala fi l Once Daily vs Tadala fi l On Demand in Clinical Subgroups of Men With Erectile Dysfunction : A Descriptive Comparison Using the Integrated Tadala fi l Databases

M. Oelke, J. Mulhall, M. Rosenberg, 2022 .

The Co-occurring Syndrome-Coexisting Erectile Dysfunction and Benign Prostatic Hyperplasia and Their Clinical Correlates in Aging Men: Results From the National Health and Nutrition Examination Survey.

K. McVary, R. Rosen, A. Burnett, 2015, Urology.

Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.

Edward D. Kim, R. Shabsigh, A. Seftel, 2013, The journal of sexual medicine.

Minimal clinically important differences in the vaginal insertion and successful intercourse items of the sexual encounter profile.

A. Araujo, R. Rosen, Kerstin R. Allen, 2012, The journal of sexual medicine.

Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale.

A. Araujo, R. Rosen, Kerstin R. Allen, 2011, European urology.

Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.

C. Roehrborn, K. McVary, G. Brock, 2014, The Journal of urology.

The role of initial success rates and other factors in determining reliability of outcomes of phosphodiesterase inhibitor therapy for erectile dysfunction: a pooled analysis of 17 placebo-controlled trials of tadalafil for use as needed.

A. Araujo, R. Rosen, H. Litman, 2013, The journal of sexual medicine.

Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001–2008

K. McVary, R. Rosen, A. Burnett, 2015, International journal of clinical practice.

Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs ⩾50 years

R. Shinghal, A. Seftel, E. Kim, 2013, International Journal of Impotence Research.

Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study.

R. Hayes, M. Maggi, S. Dowsett, 2016, The Journal of urology.

9-Month Efficacy and Safety Study of Testosterone Solution 2% for Sex Drive and Energy in Hypogonadal Men.

G. Brock, K. Kinchen, D. Heiselman, 2016, The Journal of urology.

Delayed Ejaculation and Associated Complaints: Relationship to Ejaculation Times and Serum Testosterone Levels.

A. Morgentaler, S. Althof, C. Donatucci, 2017, The journal of sexual medicine.

Amount of Testosterone on Laundered Clothing After Use of Testosterone Topical 2% Solution by Healthy Male Volunteers.

M. Mitchell, D. Small, D. Muram, 2016, Journal of Sexual Medicine.

Effect of deodorant and antiperspirant use and presence or absence of axillary hair on absorption of testosterone 2% solution applied to men's axillae.

M. Mitchell, D. Small, D. Satonin, 2014, The journal of sexual medicine.

Testosterone Replacement in Androgen-Deficient Men With Ejaculatory Dysfunction: A Randomized Controlled Trial.

D. Paduch, S. Basaria, P. Polzer, 2015, The Journal of clinical endocrinology and metabolism.

Psychometric testing of two new patient‐reported outcome instruments for the evaluation of treatment for hypogonadism

R. Hayes, K. Kinchen, D. Heiselman, 2016, International journal of clinical practice.

Nonresponders, partial responders, and complete responders to PDE5 inhibitors therapy according to IIEF criteria: validation of an anchor-based treatment responder classification.

May H. Yang, R. Rosen, H. Litman, 2013, The journal of sexual medicine.

Relationship between erectile function and sexual self-confidence: a path analytic model in men being treated with tadalafil

R. Rosen, S. Althof, X. Ni, 2014, International Journal of Impotence Research.

A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.

A. Seftel, X. Ni, E. Goldfischer, 2014, The journal of sexual medicine.